Navigation Links
Tocagen's First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma
Date:6/7/2011

SAN DIEGO, June 7, 2011 /PRNewswire/ -- Tocagen Inc. today announced the company is enrolling patients with recurrent high grade glioma, such as those with glioblastoma multiforme (GBM, Grade 4), in its first-in-human clinical trial of Toca 511.

The multicenter, open-label study is evaluating the safety and tolerability of single ascending doses of Toca 511 administered intratumorally followed by cycles of the prodrug 5-fluorocytosine (5-FC) in patients who have failed prior surgery and chemoradiation. Patients will receive a single dose of Toca 511, a gene transfer viral vector that delivers a cytosine deaminase (CD) gene to tumor cells. After the vector is allowed to spread through the tumor for approximately 4 weeks, patients receive a six-day course of oral 5-FC. In the tumor cells expressing the CD gene, 5-FC is converted by the CD enzyme into the anti-cancer drug 5-fluorouracil (5-FU). Subsequently, patients receive additional cycles of oral 5-FC monthly for up to six months.

"There are limited treatment options available for patients with glioblastoma. It is therefore a priority to explore potential new therapies to treat this form of cancer," said Timothy Cloughesy, M.D., Director of the Neuro-Oncology Program at the University California, Los Angeles Jonsson Cancer Center and a principal investigator for the Toca 511 study. "Toca 511 is a novel approach that offers new hope to combating this deadly disease."

In studies performed in animal models of GBM, nearly all animals treated with Toca 511 followed by 5-FC lived for the duration of the study (six months), compared to less than two months for control (untreated) animals. Toca 511 spread through the brain tumors and, following 5-FC treatment, marked tumor regression occurred while healthy brain tissue was unharmed.

"Unlike conventional cancer treatments in which toxic side effects limit ho
'/>"/>

SOURCE Tocagen Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
2. Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System
3. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
4. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
5. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
6. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
7. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
8. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
9. Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers
10. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
11. NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 The report "Silage ... Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), ... 2020", Silage Inoculants & Enzymes Market is expected to ... 4.0% from 2015 to 2020. Browse ... through 194 P ages and an ...
(Date:7/2/2015)...  Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Sawae Technologica Ltda., an X-ray system equipment manufacturer based ... its Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... million, significant healthcare technical advancements and efficiencies are required. ...
(Date:7/2/2015)... de 2015 BGI anunció hoy que su ... rendimiento en Hong Kong ha ... instalación de BGI en Hong Kong ... generación que recibe la certificación CAP en ... prácticas de laboratorio clínico. Junto con el exitoso proceso ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3BGI recibe la acreditación del College of American Pathologists (CAP) 2
... 8, 2011 Life Recovery Systems announced today that ... Premier Purchasing Partners, LP, the group purchasing unit of ... available by contract to its more than 75,000 healthcare ... GPO contract, Robert Neary, LRS Director of Marketing commented, ...
... 2011 On the heels of launching its enhanced ... LLY ) introduces the Lilly Health Channel ... on health and wellness, employee and community outreach efforts, health ... Videos on the channel spotlight issues like the growing ...
Cached Medicine Technology:Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 2Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 3Lilly Health Channel Debuts on YouTube 2
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top ... mesothelioma with even minimal asbestos exposure. Click here to read the complete story ... of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice ...
(Date:7/3/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . To be held from March 4th - 6th, the 2016 (a previous ... Galleria Dallas. , Designed to take participants from the basic training and fundamentals of ...
(Date:7/3/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership ... national president recruitment for Regional Care, Inc. in Scottsbluff, Neb. One ... has recently placed more than 1,000 healthcare executives into organizations. , As ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national chief nursing officer recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... took place on June 25, 2015 at 1:00pm. The Association welcomed speaker C. ... pertaining to injured bicyclists and practical points of investigating these types of cases. ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... limited pressure to achieve the ,thin and beautiful, ideal have ... study looking at five factors that may help young women ... of a society where discontent with appearance is common among ... of Arizona in the US, and colleagues is published online ...
... stimulating immune cells to more effectively battle cancerous tumors, ... effect, driving these intracellular fighters to exhaustion, a Mayo ... Journal of Clinical Investigation . The ... testing the treatment,s ability to ramp up the body,s ...
... News) -- Children who wake up at night and are allowed ... to be overweight than kids put back into their own bed, ... children aged 2 to 6 who had an increased risk of ... were overweight before becoming pregnant or their mothers were poor. ...
... News) -- Everyone knows teen behavior is highly influenced by their ... influence whether or not a teen drinks alcohol or uses drugs. ... their child,s drug or alcohol use, or worse, condone it, that ... study found. "Among friendship groups with ,good parents, there,s a ...
... HealthDay Reporter , TUESDAY, May 8 (HealthDay News) -- Women who ... to worry about gaining weight after the device is implanted, new ... aged 15 to 44 who were using two different types of ... About half of the women had a non-hormonal IUD containing copper ...
... A Wayne State University researcher believes a better ... one day help at-risk adolescents transition more quickly to ... To further that understanding, Tim Bogg, Ph.D., assistant ... and Sciences, has received a three-year, $731,000 grant from ...
Cached Medicine News:Health News:Self-worth needs to go beyond appearance 2Health News:Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment 2Health News:Study: Kids Who Sleep in Parents' Bed Less Likely to Be Overweight 2Health News:Friends' Parents Can Sway Teens' Odds for Drinking, Smoking 2Health News:IUD Use Tied to Modest Weight Loss 2Health News:IUD Use Tied to Modest Weight Loss 3Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 2Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 3
... provide excellent protection and ease of use. ... closer to an adhesive in molecular weight ... to maintain viscosity at high shear rates, ... for superb performance during capsulorhexis, phaco, IOL ...
151 channels cover the entire head with a high density, with provisions for the eyes and ears. Patients and subjects are examined in a comfortable seated position or laying down....
... The Magnes 1300 C is ideal for ... brain and other parts of the body. Often ... its possibilites, including magnetocardiography, gastrointestinal tract, fetal, spinal ... ,The 1300 C, with its 67 detector ...
... neutral pH bone putty that contains calcium-based ... for decades in orthopedic surgery. These materials ... source of bone to help the patient ... microstructure to enhance bone regeneration, provide optimal ...
Medicine Products: